Cencora, Inc. COR is well-poised for growth ... The company has a market capitalization of $44.82 billion. Image Source: Zacks Investment Research COR’s bottom line is anticipated to improve ...

Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 8.3% over the past month. The stock hit a new 52-week high of $271.86 in the previous session.

The image below, which you can click on for greater detail, shows that at December 2024 Cencora had debt of US$8.15b, up from US$4.78b in one year. However, because it has a cash reserve of US$3 ...

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent ...

Cencora COR has outperformed the market over the past 10 years by 7.55% on an annualized basis producing an average annual return of 18.31%. Currently, Cencora has a market capitalization of $52. ...

Argus analyst David Toung raised the firm’s price target on Cencora (COR) to $280 from $270 and keeps a Buy rating on the shares. The company delivered strong results for Q1 and expects topline ...

Baird raised the firm’s price target on Cencora (COR) to $307 from $305 and keeps an Outperform rating on the shares. The firm noted it was another beat and raise quarter. Published first on ...

Cencora, Inc. COR is well-poised for growth ... delivering an average surprise of 4.94%. Image Source: Zacks Investment ...